Testing effectiveness (Phase 2)Study completedNCT00003895
What this trial is testing
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
Who this might be right for
Recurrent MelanomaStage IA MelanomaStage IB Melanoma+6 more
National Cancer Institute (NCI) 36